explore -WSS

explore

author：Wikipedia 2025-09-30 22:27:19 - browse：155

Kuldeep Singh Rajput -- health tech coverage from STAT — Kuldeep Singh Rajput has left his role as CEO of Biofourmis. World Economic Forum

A month after conducting significant layoffs, Biofourmis is out a CEO: Kuldeep Singh Rajput, one of the company’s founders, has quietly stepped down from his role.

A Biofourmis spokesperson confirmed Rajput’s departure to STAT on Wednesday, and said that while the company hunts for a new CEO it will be helmed by a committee of executives overseen by new board member Ben Wanamaker, a partner at Biofourmis investor General Atlantic. The Boston-based company was valued at $1.3 billion following a $320 million Series D financing round which closed last summer and brought big names to Biofourmis: CVS Health was an investor, and Omar Ishrak, former CEO of Medtronic, and Sachin Jain, CEO of the SCAN Health Plan joined the board.

Founded in 2015, Biofourmis has been developing a dizzying array of tech-enabled care offerings, including home-based care services for hospitals, clinical trials support for biopharma companies, and a pipeline of software-based interventions for heart failure and other conditions.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： FTC sues over Novant Health acquisition of two N.C. hospitals

WSS

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Group behind ProMed defends move to subscription

Flint parents haunted by uncertainty, fears of lead poisoning

Merck, Johnson & Johnson CEOs will testify on high drug prices

Zyn nicotine pouches become unlikely player in latest culture war

How to ethically and practically extend health care to all

focus

explore

focus

Affirmative action in medical school literally saved lives

Investment in vaccine development is lagging, report finds

Sports medicine is finally prioritizing gender equality

How generative AI ratchets up security threats for health systems

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How to ethically and practically extend health care to all

Anesthesiologist group: stop taking Ozempic before surgery

Personalized medicine goes far beyond genetics

Dobbs anniversary: the lost opportunity of abortion as health care

Vertex non

hotspot

Biotech startup Celsius cuts 75% of staff ahead of first trial start

2 officers injured in shooting in Orlando, police say

Group behind ProMed defends move to subscription

Merck, Johnson & Johnson CEOs will testify on high drug prices

Vertex non

Medicare drug price negotiation legal challenge met with skepticism

leisure time

explore

leisure time

focus